Mary Johnson
Nurse Practitioner · Davenport, IANPI 1104085497
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $26,895 of the $29,539 with a category attached, or 91.0%. Organon accounts for 91.5% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $8,551, more than ten times the $96 reported in 2021. Among nurse practitioner clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $208.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$27K
- Astellas Pharma US Inc$579
- AbbVie$409
- Exeltis, USA Inc.$275
- Bayer$153
- Biogen$131
- plus $965 from 19 others
What the payments were for
- Speaking & faculty fees$26,89591%
- Food & beverage$2,6459%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 41 | $27,027 |
| Astellas Pharma US Inc | 13 | $579 |
| AbbVie | 20 | $409 |
| Exeltis, USA Inc. | 9 | $275 |
| Bayer | 11 | $153 |
| Biogen | 7 | $131 |
| Acella Pharmaceuticals, LLC | 1 | $130 |
| Galderma Laboratories, L.p. | 2 | $105 |
| Hologic Sales And Service, LLC | 5 | $100 |
| Daiichi Sankyo Inc. | 4 | $85 |
| Coopersurgical, Inc. | 5 | $70 |
| Myovant Sciences Inc. | 3 | $69 |
| Pfizer | 3 | $65 |
| Axonics, Inc. | 2 | $55 |
| Novo Nordisk | 3 | $50 |
| Johnson & Johnson | 2 | $49 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Merck | 2 | $30 |
| Octapharma USA, Inc. | 1 | $28 |
| Exact Sciences | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Medline Industries LP | 1 | $15 |
| Medtronic | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$23,535
- Veozah$387
- NP Thyroid 60$130
How this compares
$29,539 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 69 | $4,081 |
| ValacyclovirValacyclovir Hcl | 16 | $477 |
| Estradiol (Twice Weekly)Estradiol | 12 | $425 |
| ProgesteroneProgesterone, Micronized | 15 | $417 |
| Alendronate Sodium | 27 | $202 |
| Alprazolam | 18 | $50 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Davenport
- Brittany SpiveyDavenport$4K
- Lisa VannoyDavenport$3K
- Nicole MorganDes Moines$106K
- Julie CoffeyIowa City$31K
- Megan Hart FernandezCedar Rapids$19K
- Carla HuberCedar Rapids$18K
- Beth ChiaWest Des Moines$15K
- Margaret KinneyRed Oak$13K
- Abbey ModlinDes Moines$12K
- Jonathon HenningsWaterloo$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.